D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
The striatum, which is the major component of the basal ganglia in the brain, is regulated in part by dopaminergic input from the substantia nigra. Severe movement disorders result from the loss of striatal dopamine in patients with Parkinson's disease. Rats with lesions of the nigrostriatal dopamine pathway caused by 6-hydroxydopamine (6-OHDA) serve as a model for Parkinson's disease and show alterations in gene expression in the two major output systems of the striatum to the globus pallidus and substantia nigra. Striatopallidal neurons show a 6-OHDA-induced elevation in their specific expression of messenger RNAs (mRNAs) encoding the D 2 dopamine receptor and enkephalin, which is reversed by subsequent continuous treatment with the D 2 agonist quinpirole. Conversely, striatonigral neurons show a 6-OHDA-induced reduction in their specific expression of mRNAs encoding the D 1 dopamine receptor and substance P, which is reversed by subsequent daily injections of the D 1 agonist SKF-38393. This treatment also increases dynorphin mRNA in striatonigral neurons. Thus, the differential effects of dopamine on striatonigral and striatopallidal neurons are mediated by their specific expression of D 1 and D 2 dopamine receptor subtypes, respectively.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The NAc is composed of a vast array of transcriptionally distinct neuronal subtypes, where medium spiny neurons (MSNs) make up the majority (>95%) of the cells (16).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [16]
In the citing paper
“These neurons are defined by their transcriptional profiles, including dopamine receptor 1 (D1) vs. dopamine receptor 2 (D2) expression, substance P and enkephalin, and other enriched genes (16–18).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [16]
Citations
Cites
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
Multiple receptors for dopamine
Kebabian, J. W., & Calne, D. B. (1979) · Nature · doi:10.1038/277093a0 · Cited by 3,725
DOPAMINE (3-HYDROXYTYRAMINE) AND BRAIN FUNCTION
HORNYKIEWICZ, O. (1966) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07154-6 · Cited by 1,442
Fluoro-gold: a new fluorescent retrograde axonal tracer with numerous unique properties
Schmued, L. C., & Fallon, J. H. (1986) · Brain Research · doi:10.1016/0006-8993(86)91199-6 · Cited by 886
Freund, T. F., Powell, J. F., & Smith, A. D. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90294-x · Cited by 865
Hikosaka, O., & Wurtz, R. H. (1983) · Journal of Neurophysiology · doi:10.1152/jn.1983.49.5.1285 · Cited by 808
Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain.
Young, W. S., Bonner, T. I., & Brann, M. R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9827 · Cited by 743
Gerfen, C. R., & Scott Young, W. (1988) · Brain Research · doi:10.1016/0006-8993(88)91217-6 · Cited by 658
Self-citationMultiple D2 dopamine receptors produced by alternative RNA splicing
Monsma, F. J., McVittie, L. D., Gerfen, C. R., Mahan, L. C., & Sibley, D. R. (1989) · Nature · doi:10.1038/342926a0 · Cited by 641
Self-citationProjection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin
Kawaguchi, Y., Wilson, C., & Emson, P. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-10-03421.1990 · Cited by 565
Research works printed but not linked: 1
- HONG, J.S., ADVANCES IN BIOCHEMICAL PSYCHOPHARMACOLOGY 24: 223 (1980).
Cited by
Items 701–800 of 1,013
Dyskinesias and dopamine cell replacement in Parkinson's disease: a clinical perspective
Hagell, P., & Cenci, M. A. (2004) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2004.10.013 · Cited by 85
Neurochemical and behavioural indices of exercise reward are independent of exercise controllability
Herrera, J. J., Fedynska, S., Ghasem, P. R., Wieman, T., Clark, P., Gray, N. A., Loetz, E. C., Campeau, S., Fleshner, M., & Greenwood, B. N. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13193 · Cited by 85
Graham, W. C., Sambrook, M. A., & Crossman, A. R. (1993) · Brain Research · doi:10.1016/0006-8993(93)90694-i · Cited by 85
ERK/MAPK Signaling Is Required for Pathway-Specific Striatal Motor Functions
Hutton, S. R., Otis, J. M., Kim, E. M., Lamsal, Y., Stuber, G. D., & Snider, W. D. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0473-17.2017 · Cited by 84
Marti, M., Trapella, C., Viaro, R., & Morari, M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4346-06.2007 · Cited by 84
Papp, M., Gruca, P., & Willner, P. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00349-4 · Cited by 84
Calabresi, P., De Murtas, M., Mercuri, N. B., & Bernardi, G. (1992) · Annals of Neurology · doi:10.1002/ana.410310404 · Cited by 79
Bolam, J. P., & Ellender, T. J. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.08.013 · Cited by 83
Silverdale, M., McGuire, S., McInnes, A., Crossman, A. R., & Brotchie, J. M. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7649 · Cited by 83
The pathomechanisms underlying Parkinson's disease
Jellinger, K. A. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.877842 · Cited by 83
Nisenbaum, E. S., Grace, A. A., & Berger, T. W. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90403-o · Cited by 83
Dopamine D1 and D2 receptor contributions to L-DOPA-induced dyskinesia in the dopamine-depleted rat
Taylor, J. L., Bishop, C., & Walker, P. D. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.06.013 · Cited by 83
Nadjar, A., Brotchie, J. M., Guigoni, C., Li, Q., Zhou, S.-B., Wang, G.-J., Ravenscroft, P., Georges, F., Crossman, A. R., & Bezard, E. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2582-06.2006 · Cited by 82
Steiner, H., & Gerfen, C. R. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19961223)376:4<530::aid-cne3>3.0.co;2-2 · Cited by 82
Self-citationNovel Therapeutic GPCRs for Psychiatric Disorders
Komatsu, H. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160614109 · Cited by 82
Borgkvist, A., Avegno, E. M., Wong, M. Y., Kheirbek, M. A., Sonders, M. S., Hen, R., & Sulzer, D. (2015) · Neuron · doi:10.1016/j.neuron.2015.08.022 · Cited by 82
Mela, F., Marti, M., Bido, S., Cenci, M. A., & Morari, M. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.09.015 · Cited by 82
Heckman, P. R. A., Blokland, A., Bollen, E. P. P., & Prickaerts, J. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.007 · Cited by 74
Differential regulation of dopamine D1 and D2 signaling by nicotine in neostriatal neurons
Hamada, M., Higashi, H., Nairn, A. C., Greengard, P., & Nishi, A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02574.x · Cited by 82
Anxiolytic 2,3-benzodiazepines, their specific binding to the basal ganglia
Horváth, E. J., Horváth, K., Hámori, T., Fekete, M. I. K., Sólyom, S., & Palkovits, M. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00020-9 · Cited by 82
Cenci, M. A., Campbell, K., & Björklund, A. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90062-k · Cited by 82
Inglis, W. L., Allen, L. F., Whitelaw, R. B., Latimer, M. P., Brace, H., & Winn, P. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90459-6 · Cited by 82
Heterogeneous development of calbindin‐D28K expression in the striatal matrix
Liu, F., & Graybiel, A. M. (1992) · Journal of Comparative Neurology · doi:10.1002/cne.903200304 · Cited by 72
Nicotine and endogenous opioids: neurochemical and pharmacological evidence
Hadjiconstantinou, M., & Neff, N. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.11.010 · Cited by 81
Striatal synaptic adaptations in Parkinson's disease
Shen, W., Zhai, S., & Surmeier, D. J. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105686 · Cited by 81
Zeng, B. ‐., Dass, B., Owen, A., Rose, S., Cannizzaro, C., Tel, B. C., & Jenner, P. G. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00762-4 · Cited by 81
Androgens Induce Dopaminergic Neurotoxicity via Caspase-3-Dependent Activation of Protein Kinase Cδ
Cunningham, R. L., Giuffrida, A., & Roberts, J. L. (2009) · Endocrinology · doi:10.1210/en.2009-0640 · Cited by 73
Martinu, K., & Monchi, O. (2013) · Behavioral Neuroscience · doi:10.1037/a0031226 · Cited by 81
Striatal glutamatergic mechanisms and extrapyramidal movement disorders
Chase, T. N., Bibbiani, F., & Oh, J. D. (2003) · Neurotoxicity Research · doi:10.1007/bf03033378 · Cited by 81
Self-citationBasal ganglia —input, neural activity, and relation to the cortex
Graybiel, A. M. (1991) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(05)80043-1 · Cited by 81
Kung, V., Hassam, R., Morton, A. J., & Jones, S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.03.036 · Cited by 81
Wang, Q., Jolly, J. P., Surmeier, D. J., Mullah, B., Lidow, M. S., Bergson, C. M., & Robishaw, J. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104981200 · Cited by 81
Amphetamine‐ and cocaine‐induced fos in the rat striatum depends on D2 dopamine receptor activation
Ruskin, D. N., & Marshall, J. F. (1994) · Synapse · doi:10.1002/syn.890180309 · Cited by 81
Dopamine receptor functions: lessions from knockout mice
Glickstein, S. B., & Schmauss, C. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00145-0 · Cited by 81
Inhibitory control of the GABAergic transmission in the rat neostriatum by D2 dopamine receptors
Delgado, A., Sierra, A., Querejeta, E., Valdiosera, R., & Aceves, J. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00495-9 · Cited by 81
Bernard, V., Moine, C. L., & Bloch, B. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90108-z · Cited by 81
Characterization of Gene Organization and Promoter Region of the Rat Dopamine D1 Receptor Gene
Zhou, Q., Li, C., & Civelli, R. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb11023.x · Cited by 81
Neely, M. D., Schmidt, D. E., & Deutch, A. Y. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.06.044 · Cited by 80
A unifying model of the role of the infralimbic cortex in extinction and habits
Barker, J. M., Taylor, J. R., & Chandler, L. J. (2014) · Learning & Memory · doi:10.1101/lm.035501.114 · Cited by 80
Brain networks in Huntington disease
Eidelberg, D., & Surmeier, D. J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45646 · Cited by 80
Müller, N., Riedel, M., Eggert, T., & Straube, A. M. (1999) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060050059 · Cited by 80
Antisense oligodeoxynucleotide inhibits D2 dopamine receptor-mediated behavior and D2 messenger RNA
Weiss, B., Zhou, L.-W., Zhang, S. P., & Qin, Z. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90426-g · Cited by 80
Ehrman, L. A., Mu, X., Waclaw, R. R., Yoshida, Y., Vorhees, C. V., Klein, W. H., & Campbell, K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308275110 · Cited by 79
Tecuapetla, F., Koos, T., Tepper, J. M., Kabbani, N., & Yeckel, M. F. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.6145-08.2009 · Cited by 79
Microcircuits in nucleus accumbens’ shell and core involved in cognition and reward
Meredith, G. E., & Totterdell, S. (1999) · Psychobiology · doi:10.3758/bf03332112 · Cited by 79
Role of Striatum in the Pause and Burst Generation in the Globus Pallidus of 6-OHDA-Treated Rats
Kita, H., & Kita, T. (2011) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2011.00042 · Cited by 79
Contrast enhancement: a physiological effect of striatal dopamine?
Nicola, S. M., Hopf, F. W., & Hjelmstad, G. O. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0929-z · Cited by 79
Mitrano, D. A., & Smith, Y. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.21214 · Cited by 79
Hansen, H. H., Ebbesen, C., Mathiesen, C., Weikop, P., Rønn, L. C. B., Waroux, O., Scuvée‐Moreau, J., Seutin, V., & Mikkelsen, J. D. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.106757 · Cited by 79
Miyamoto, Y., Katayama, S., Shigematsu, N., Nishi, A., & Fukuda, T. (2018) · Brain Structure and Function · doi:10.1007/s00429-018-1749-3 · Cited by 79
Circulating Triglycerides Gate Dopamine-Associated Behaviors through DRD2-Expressing Neurons
Berland, C., Montalban, E., Perrin, E., Miceli, M. D., Nakamura, Y., Martinat, M., Sullivan, M., Davis, X. S., Shenasa, M. A., Martin, C., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.02.010 · Cited by 79
LaHoste, G. J., Henry, B. L., & Marshall, J. F. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06666.2000 · Cited by 79
Knable, M. B., Hyde, T. M., Herman, M. M., Carter, J. M., Bigelow, L. B., & Kleinman, J. E. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90593-2 · Cited by 79
Steiner, H., & Gerfen, C. R. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00241-3 · Cited by 79
Self-citationLevodopa-induced dyskinesias and their management
Sorbo, F. D., & Albanese, A. (2008) · Journal of Neurology · doi:10.1007/s00415-008-4006-5 · Cited by 79
Nisenbaum, E. S., & Berger, T. W. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90402-n · Cited by 79
Direct-Pathway Striatal Neurons Regulate the Retention of Decision-Making Strategies
Ferguson, S. M., Phillips, P. E. M., Roth, B. L., Wess, J., & Neumaier, J. F. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4783-12.2013 · Cited by 78
Xu, W., Zhu, J. P. Q., & Angulo, J. A. (2005) · Synapse · doi:10.1002/syn.20185 · Cited by 78
Burns, J. A., Kroll, D. S., Feldman, D. E., Liu, C. K., Manza, P., Wiers, C. E., Volkow, N. D., & Wang, G. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00626 · Cited by 78
Targeting Sensory and Motor Integration for Recovery of Movement After CNS Injury
Asan, A. S., McIntosh, J. R., & Carmel, J. B. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.791824 · Cited by 78
Locomotion activates PKA through dopamine and adenosine in striatal neurons
Ma, L., Day‐Cooney, J., Jáidar, O., Muniak, M. A., Qin, M., Ding, J., Mao, T., & Zhong, H. (2022) · Nature · doi:10.1038/s41586-022-05407-4 · Cited by 78
Ding, Y., Restrepo, J., Won, L., Hwang, D., Kim, K., & Kang, U. J. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.03.013 · Cited by 78
Morphological changes of glutamatergic synapses in animal models of Parkinson’s disease
Villalba, R. M., Mathai, A., & Smith, Y. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00117 · Cited by 78
Gonzales, K. K., Paré, J., Wichmann, T., & Smith, Y. (2013) · The Journal of Comparative Neurology · doi:10.1002/cne.23295 · Cited by 78
Cunningham, M. W., & Cox, C. J. (2016) · Acta Physiologica · doi:10.1111/apha.12614 · Cited by 69
Wichmann, T., Bergman, H., & DeLong, M. R. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1736-5 · Cited by 78
Neural systems for control of voluntary action ? A hypothesis
HIKOSAKA, O. (1998) · Advances in Biophysics · doi:10.1016/s0065-227x(98)80004-x · Cited by 78
Heusner, C. L., & Palmiter, R. D. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1474-05.2005 · Cited by 65
Ionotropic and metabotropic GABA and glutamate receptors in primate basal ganglia
Smith, Y., Charara, A., Paquet, M., Kieval, J. Z., Paré, J., Hanson, J. E., Hubert, G. W., Kuwajima, M., & Levey, A. I. (2001) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(01)00098-9 · Cited by 78
Expression of Cre recombinase in dopaminoceptive neurons
Lemberger, T., Parlato, R., Dassesse, D., Westphal, M., Casanova, E., Turiault, M., Tronche, F., Schiffmann, S. N., & Schütz, G. (2007) · BMC Neuroscience · doi:10.1186/1471-2202-8-4 · Cited by 77
Striatal NELF-mediated RNA polymerase II stalling controls l -dopa induced dyskinesia
Bastide, M. F., Bido, S., Duteil, N., & Bézard, E. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.10.013 · Cited by 73
Rico, A. J., Dopeso‐Reyes, I. G., Martínez‐Pinilla, E., Sucunza, D., Pignataro, D., Roda, E., Marín-Ramos, D., Labandeira-García, J. L., George, S. R., Franco, R., et al. (2016) · Brain Structure and Function · doi:10.1007/s00429-016-1306-x · Cited by 77
Radja, F., Mansari, M. E., Soghomonian, J., Dewar, K. M., Ferron, A., Reader, T. A., & Descarries, L. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90011-4 · Cited by 77
Wang, J. Q., & McGinty, J. F. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36678-9 · Cited by 77
Endocannabinoid Signaling Mediates Psychomotor Activation by Adenosine A 2A Antagonists
Lerner, T. N., Horne, E. A., Stella, N., & Kreitzer, A. C. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5844-09.2010 · Cited by 76
Dopamine Modulation of GABA Tonic Conductance in Striatal Output Neurons
Janssen, M. J., Ade, K. K., Fu, Z., & Vicini, S. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4737-08.2009 · Cited by 76
Molecular Mechanisms of Psychostimulant-induced Structural Plasticity
Dietz, D. M., Dietz, K. C., Nestler, E. J., & Russo, S. J. (2009) · Pharmacopsychiatry · doi:10.1055/s-0029-1202847 · Cited by 76
Neostriatal dopamine receptors
Gerfen, C. R., & Keefe, K. A. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90022-1 · Cited by 76
Self-citationPropofol exerts anti-anhedonia effects via inhibiting the dopamine transporter
Zhu, X., Li, J., Qiu, G., Wang, L., Lu, C., Guo, Y., Yang, K., Cai, F., Xu, T., Yuan, T., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.02.017 · Cited by 76
Targeting Neuronal Populations of the Striatum
Durieux, P. F., Schiffmann, S. N., & d’Exaerde, A. D. K. (2011) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2011.00040 · Cited by 76
Neuromodulation of excitatory synaptogenesis in striatal development
Kozorovitskiy, Y., Peixoto, R. T., Wang, W., Saunders, A. B., & Sabatini, B. L. (2015) · eLife · doi:10.7554/elife.10111 · Cited by 76
High-Frequency Activation of Nucleus Accumbens D1-MSNs Drives Excitatory Potentiation on D2-MSNs
Francis, T. C., Yano, H., Demarest, T. G., Shen, H., & Bonci, A. (2019) · Neuron · doi:10.1016/j.neuron.2019.05.031 · Cited by 76
Tomiyama, M., Kimura, T., Maeda, T., Kannari, K., Matsunaga, M., & Baba, M. (2005) · Neuroscience Research · doi:10.1016/j.neures.2005.03.004 · Cited by 76
Reiner, A. J. (2002) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00667-0 · Cited by 76
Shin, R.-M., Masuda, M., Miura, M., Sano, H., Shirasawa, T., Song, W., Kobayashi, K., & Aosaki, T. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-37-11662.2003 · Cited by 76
Drug addiction: from bench to bedside
Cheron, J., & Kerchove d’Exaerde, A. D. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01542-0 · Cited by 75
“The GABA medium-sized spiny neurons (MSNs, ~95% of striatal neurons), which are targets of glutamatergic and dopaminergic inputs, form two pathways [15].”
Backgroundl‐DOPA‐induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?
Carta, A. R., Mulas, G., Bortolanza, M., Duarte, T., Pillai, E., Fisone, G., Vozari, R. R., & Del‐Bel, E. (2017) · European Journal of Neuroscience · doi:10.1111/ejn.13482 · Cited by 75
Abnormal repetitive behaviours: shared phenomenology and pathophysiology
Muehlmann, A. M., & Lewis, M. H. (2012) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2011.01519.x · Cited by 75
Dopamine in the tail of the striatum facilitates avoidance in threat–reward conflicts
Tsutsui‐Kimura, I., Tian, Z. M., Amo, R., Zhuo, Y., Li, Y., Campbell, M. G., Uchida, N., & Watabe‐Uchida, M. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-01902-9 · Cited by 75
Gauda, E. B., Northington, F. J., Linden, J. M., & Rosin, D. L. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02314-3 · Cited by 75
Mglur4-Positive Allosteric Modulation as Potential Treatment for Parkinson’s Disease
Hopkins, C. R., Lindsley, C. W., & Niswender, C. M. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.38 · Cited by 75
Electrophysiological and Morphological Evidence for a GABAergic Nigrostriatal Pathway
Rodríguez, M., & González‐Hernández, T. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04682.1999 · Cited by 75
Drugs of Abuse and Brain Gene Expression
Torres, G., & Horowitz, J. M. (1999) · Psychosomatic Medicine · doi:10.1097/00006842-199909000-00007 · Cited by 75
Ravenscroft, P., Chalon, S., Brotchie, J. M., & Crossman, A. R. (2003) · Experimental Neurology · doi:10.1016/j.expneurol.2003.09.001 · Cited by 75
Soghomonian, J., & Laprade, N. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199710)27:2<122::aid-syn3>3.0.co;2-g · Cited by 75
Jolkkonen, J., Jenner, P. G., & MARSDEN, C. D. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00084-6 · Cited by 75
Keefe, K. A., & Gerfen, C. R. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960401)367:2<165::aid-cne1>3.0.co;2-3 · Cited by 75
Self-citationNieoullon, A. L., & Goff, L. K. (1992) · Movement Disorders · doi:10.1002/mds.870070404 · Cited by 75
Harrison, M. B., Wiley, R. G., & Wooten, G. F. (1992) · Brain Research · doi:10.1016/0006-8993(92)91111-q · Cited by 75
Parkinson's disease and D1 dopamine receptors.
Mailman, R. B., Huang, X., & Nichols, D. E. (2001) · PubMed · Cited by 74
Metadata
- Authors
- Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R.
- Affiliations
- National Institutes of Health (US)
- Venue
- Science
- Published
- 1990-12-07
- Volume
- 250
- Issue
- 4986
- Pages
- 1429-1432
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1991603311
- Cited by
- 2,967
- References
- 38
- Citations by year
- 2026: 54 · 2025: 60 · 2024: 73 · 2023: 64 · 2022: 89 · 2021: 84 · 2020: 79 · 2019: 85 · 2018: 90 · 2017: 79 · 2016: 102 · 2015: 106 · 2014: 95 · 2013: 79 · 2012: 97
- FWCI
- 27.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- dopamine D1 receptor, dopamine D2 receptor, striatonigral neurons, striatopallidal neurons, gene expression, 6-hydroxydopamine lesion, Parkinson's disease model, substantia nigra, globus pallidus, enkephalin, substance P, dynorphin, quinpirole, SKF 38393, basal ganglia, dopamine agonists
- MeSH terms
- Animals, Cerebral Cortex, Corpus Striatum, Ergolines, Gene Expression Regulation, Globus Pallidus, Hydroxydopamines, Models, Neurological, Neurons, Receptors, Dopamine, RNA, Messenger, Substantia Nigra, Thalamus, Oligonucleotide Probes, 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine, Oxidopamine, Receptors, Dopamine D1, Receptors, Dopamine D2, Quinpirole, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.